We welcome the decision by the UK Joint Committee on Vaccination and Immunisation (JCVI) to broaden the eligibility for the vaccination programme for the Shingrix recombinant herpes zoster vaccine ...
Scilex’s commercial products include: (i) ZTlido® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the relief ...